ADHα inhibitors are a class of chemical compounds designed to specifically inhibit the activity of the alcohol dehydrogenase alpha subunit (ADHα), a member of the alcohol dehydrogenase family of enzymes. ADHα is involved in the catalysis of the oxidation of alcohols into aldehydes and ketones, using NAD+ as a cofactor. This enzymatic activity is crucial in various metabolic pathways, particularly those associated with the metabolism of alcohols in the liver and other tissues. ADHα inhibitors work by binding to the enzyme's active site or allosteric regions, thereby preventing the enzyme from interacting with its natural substrates-alcohol molecules-or hindering the oxidation reaction from proceeding. Structurally, these inhibitors often resemble the substrates or cofactors of ADHα, such as alcohol molecules or nicotinamide derivatives, allowing them to effectively compete for binding at the active site and block the enzyme's catalytic function.
The development of ADHα inhibitors is based on a detailed understanding of the enzyme's structure, which is often elucidated through techniques like X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy. These methods reveal the specific features of the active site, including the arrangement of catalytic residues and binding pockets that interact with NAD+ and alcohol substrates. Armed with this structural knowledge, researchers can design inhibitors that fit precisely into these key regions, ensuring high specificity for ADHα. Computational tools, such as molecular docking simulations, are frequently used to predict how potential inhibitors will bind to the enzyme and to optimize their affinity and selectivity. Some ADHα inhibitors may also act allosterically, binding to regions of the enzyme outside the active site to induce conformational changes that reduce its overall catalytic efficiency. By inhibiting ADHα, these compounds are valuable for studying the enzyme's role in alcohol metabolism and its broader involvement in cellular redox reactions, offering insights into how ADHα contributes to metabolic regulation and the detoxification of alcohols.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram may irreversibly inactivate ADHα by binding to its copper cofactor, leading to proteasomal degradation of the enzyme and consequent decrease in expression. | ||||||
Fomepizole | 7554-65-6 | sc-252838 | 1 g | $74.00 | 1 | |
Fomepizole, by occupying the ADHα active site, could prevent its normal substrate interactions, potentially triggering a negative feedback loop that reduces ADHα synthesis. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin may downregulate ADHα expression by disrupting specific kinase-mediated pathways that lead to the transcriptional activation of ADH genes. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $106.00 $765.00 | 3 | |
Sodium (meta)arsenite can cause oxidative damage that leads to the activation of stress response pathways, culminating in the reduced transcription of ADHα. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol could decrease ADHα expression by inhibiting the activity of transcription factors specific to the ADH gene promoter sequences. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin may downregulate ADHα by hindering the binding of transcription coactivators to the ADH gene promoter, thus reducing its transcriptional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid could decrease ADHα expression by altering the differentiation status of hepatocytes and changing the repertoire of expressed enzymes. | ||||||
Lead(II) Acetate | 301-04-2 | sc-507473 | 5 g | $83.00 | ||
Lead acetate may induce epigenetic changes that lead to the silencing of the ADH gene, thereby decreasing the expression of ADHα. | ||||||
Cadmium chloride, anhydrous | 10108-64-2 | sc-252533 sc-252533A sc-252533B | 10 g 50 g 500 g | $55.00 $179.00 $345.00 | 1 | |
Cadmium chloride can trigger a cellular stress response that includes the binding of metal response elements in gene promoters, potentially leading to decreased ADHα expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate could reduce ADHα expression by depleting intracellular folate, which is necessary for the synthesis of purines and the maintenance of gene expression. | ||||||